Harrow

November is Diabetes-Related Eye Disease Awareness Month, a vital month for raising awareness about diabetic eye disease. For the 30 million Americans living with diabetes, regular eye exams and monitoring blood sugar levels can help prevent serious vision problems like diabetic retinopathy. Education and awareness are key, especially among at-risk communities. Taking proactive steps can make a significant difference in preserving vision and overall health. #Harrow #Diabetes #EyeExams #DiabeticRetinophathy #EyeHealth

Planning to attend the American Academy of Optometry 2024 Conference in Indianapolis, IN? Come visit us at booth #337 to learn more about Harrow and our product offerings. #harrow #AAOpt2024 #optometry #visitus

That’s a wrap on AAO 2024 in Chicago! The Harrow team had an incredible week, filled with engaging discussions and valuable connections with ophthalmology professionals who visited our booth. It was a pleasure sharing insights about VEVYE, IHEEZO, TRIESENCE, and the other innovative brands in our portfolio. If you missed us at AAO, visit us at Harrow.com to explore our full range of offerings and see how we're advancing eye care. #Harrow #AAO2024 #VEYVE #IHEEZO #TRIESENCE

A HUGE thank you to everyone who stopped by our booth at AAO! If you couldn't make it, no worries - we're still here for you! Connect with us anytime through our website at Harrow.com to learn about our full portfolio of products. #Harrow #AAO2024 #thanksforvisiting

Planning to attend the AAO 2024 Conference in Chicago, IL? Come visit us at booth #3844 to learn more about Harrow and our product offerings. #harrow #AAO2024 #ophthalmology #visitus

October is Blindness Awareness Month. Throughout this month, we celebrate the achievements of individuals who are blind or have visual disabilities, showcasing their resilience and contributions. By raising awareness, we can promote inclusivity and empower individuals with vision loss, ensuring they receive the resources and respect they deserve. #Harrow #VisionLoss #blindnessawareness

We are bringing TRIESENCE (triamcinolone acetonide injectable suspension) 40mg/mL back! Be the first to know when it’s available by signing up at: https://lnkd.in/eW7w-rpd

Harrow is excited to bring TRIESENCE® (triamcinolone acetonide injectable suspension) 40 mg/mL back to the U.S. market! Following five years on the FDA Drug Shortage List and being out of stock for the last two years, this trusted FDA-approved corticosteroid is once again available for visualization during vitrectomy and treating ocular inflammatory conditions that don't respond to topical treatments. Harrow CEO Mark L. Baum said, "The return of TRIESENCE to the market is a significant milestone for Harrow and for the many eyecare professionals who have long relied on this important product. We are extremely grateful to the Harrow Family and our manufacturing partners for their dedication to making this happen. We’re proud to be delivering on our mission to improve the quality of care for millions of patients.” Healthcare providers may order TRIESENCE directly through major pharmaceutical specialty distributors, including Besse Medical/Cencora, McKesson Medical-Surgical, and Cardinal Health. Initial supplies of TRIESENCE will be listed under both NDC 00078-0897-78 and NDC 82667-800-01. #Harrow #TRIESENCE #Ophthalmology #EyeCare #Pharmaceuticals https://lnkd.in/eJ7urvH4

September marked Healthy Aging Month. Throughout this month, we encourage you to dedicate attention to your eye health. As we celebrate aging with grace, let's ensure that we prioritize our vision and eye care! #Harrow #HealthyAgingMonth #Wellness #EyeHealth

✨ PHOTO RECAP ✨ We were honored to join the Harrow team and Metro Nashville Mayor Freddie O'Connell this morning at the company's $3 million expansion announcement. Nashville has the potential to become the nation’s epicenter for healthcare, and we are one step closer thanks to continued investment like this. 🙌 Learn more: https://lnkd.in/gHTTbkrE